8 employees
Ronawk develops a T-Block technology producing patient-specific biologics to treat diseases, cancer, organ injuries, and burns.
2019
$1.5M
from 1 investors over 1 rounds
Ronawk LLC raised $1.5M on July 7, 2022
Investors: Accelerate Venture Partners